Literature DB >> 28364426

Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem.

Simon Beaulieu-Bonneau1, Hans Ivers1, Bernard Guay2, Charles M Morin1,2.   

Abstract

Study objectives: To document the long-term sleep outcomes at 12 and 24 months after patients with chronic insomnia were treated with cognitive-behavioral therapy (CBT), either singly or combined with zolpidem medication.
Methods: Participants were 160 adults with chronic insomnia. They were first randomized for a six-week acute treatment phase involving CBT alone or CBT combined with nightly zolpidem, and randomized for a six-month extended treatment phase involving CBT, no additional treatment, CBT combined with zolpidem as needed, or CBT with zolpidem tapered. This paper reports results of the 12- and 24-month follow-ups on the main outcome measures derived from the Insomnia Severity Index and sleep diaries.
Results: Clinical improvements achieved 6 months following the end of treatment were well-maintained in all four conditions, with insomnia remission rates ranging from 48% to 74% at the 12-month follow-up, and from 44% to 63% at the 24-month follow-up. Participants receiving CBT with zolpidem taper in the extended treatment phase had significantly better results than those receiving CBT with continued zolpidem as needed. The magnitude of improvements on sleep diary parameters was similar between conditions, with a slight advantage for the CBT with zolpidem taper condition. The addition of extended CBT did not alter the long-term outcome over improvements obtained during the initial 6-week CBT. Conclusions: The results suggest that CBT for insomnia, when delivered alone or in combination with medication, produce durable sleep improvements up to two years after completion of treatment. These long-term results indicate that even if a combined CBT plus medication approach provide an added benefit immediately after treatment, extending CBT while tapering medication produce better sustained improvements compared to continued use of medication as needed. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  CBT; Insomnia; behavioral; medication.; nonpharmacological; sleep; treatment

Mesh:

Substances:

Year:  2017        PMID: 28364426      PMCID: PMC5804983          DOI: 10.1093/sleep/zsx002

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  10 in total

1.  Psychophysiological insomnia: combined effects of pharmacotherapy and relaxation-based treatments.

Authors: 
Journal:  Sleep Med       Date:  2000-10-01       Impact factor: 3.492

2.  Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Bjørn Bjorvatn; Odd E Havik; Gerd Kvale; Geir Høstmark Nielsen; Inger Hilde Nordhus
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

3.  Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia.

Authors:  Rengang Wu; Jinfeng Bao; Chungai Zhang; Jun Deng; Chunling Long
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

4.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.

Authors:  C M Morin; C Colecchi; J Stone; R Sood; D Brink
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

5.  The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.

Authors:  Charles M Morin; Geneviève Belleville; Lynda Bélanger; Hans Ivers
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

6.  Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study.

Authors:  Annie Vallières; Charles M Morin; Bernard Guay
Journal:  Behav Res Ther       Date:  2005-12

7.  The natural history of insomnia: a population-based 3-year longitudinal study.

Authors:  Charles M Morin; Lynda Bélanger; Mélanie LeBlanc; Hans Ivers; Josée Savard; Colin A Espie; Chantal Mérette; Lucie Baillargeon; Jean-Pierre Grégoire
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.

Authors:  Gregg D Jacobs; Edward F Pace-Schott; Robert Stickgold; Michael W Otto
Journal:  Arch Intern Med       Date:  2004-09-27

9.  Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.

Authors:  Charles M Morin; Annie Vallières; Bernard Guay; Hans Ivers; Josée Savard; Chantal Mérette; Célyne Bastien; Lucie Baillargeon
Journal:  JAMA       Date:  2009-05-20       Impact factor: 56.272

10.  Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication.

Authors:  Charles M Morin; Simon Beaulieu-Bonneau; Hans Ivers; Annie Vallières; Bernard Guay; Josée Savard; Chantal Mérette
Journal:  Sleep Med       Date:  2014-03-31       Impact factor: 3.492

  10 in total
  7 in total

1.  Does total sleep time substantially increase after cognitive behavioral therapy for insomnia?

Authors:  Hannah Scott; Janet M Y Cheung; Alexandria Muench; Hans Ivers; Michael A Grandner; Leon Lack; Charles M Morin; Michael Perlis
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

2.  The Role of Mindfulness in the Insomnia Severity of Female Chronic Hypnotic Users.

Authors:  Daniela Curado; Viviam Barros; Emérita Opaleye; Sarah Bowen; Helena Hachul; Ana Regina Noto
Journal:  Int J Behav Med       Date:  2018-10

Review 3.  Sleep Management Among Patients with Substance Use Disorders.

Authors:  Subhajit Chakravorty; Ryan G Vandrey; Sean He; Michael D Stein
Journal:  Med Clin North Am       Date:  2018-07       Impact factor: 5.456

Review 4.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

5.  What do hypnotics cost hospitals and healthcare?

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2017-04-21

Review 6.  We know CBT-I works, now what?

Authors:  Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis
Journal:  Fac Rev       Date:  2022-02-01

7.  Mobile App Use for Insomnia Self-Management in Urban Community-Dwelling Older Korean Adults: Retrospective Intervention Study.

Authors:  Kyungmi Chung; Seoyoung Kim; Eun Lee; Jin Young Park
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-24       Impact factor: 4.773

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.